Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Prostatic Neoplasms 12Neoplasms 11Neuroendocrine Tumors 9Breast Neoplasms 9Lung Neoplasms 6Neoplasm Metastasis 4Multiple Myeloma 4Disease 4Uterine Cervical Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma 3Head and Neck Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Neoplastic Cells, Circulating 2Mouth Neoplasms 2Lymphoma, Follicular 2Liver Neoplasms 2Leukemia 2Hypoxia 2Hodgkin Disease 2Glioma 2Esophageal Neoplasms 2Carcinoma, Neuroendocrine 2Brain Neoplasms 2

Interventions

Temozolomide 162Radiosurgery 115Radiotherapy 100Bevacizumab 96Magnetic Resonance Spectroscopy 65Carboplatin 48Etoposide 34pembrolizumab 33Surgical Procedures, Operative 33Irinotecan 33Nivolumab 32Cyclophosphamide 32Erlotinib Hydrochloride 31Radiation 30Carmustine 28Cisplatin 25Lomustine 24Trastuzumab 23Ipilimumab 23Filgrastim 23Vincristine 20Mental Status and Dementia Tests 20Aminolevulinic Acid 19Topotecan 18Pemetrexed 18Capecitabine 18Specimen Handling 17Sorafenib 15Radiotherapy, Intensity-Modulated 15Imatinib Mesylate 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Brain Neoplasms × Positron Emission Tomography Computed Tomography × Clear all
NCT06055790 2025-09-03

Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis

University of Arizona

Phase 2 Recruiting
20 enrolled
CNS

Brain Neoplasms

NCT01604512 2025-04-08

A Comparison of MRI Perfusion and FDG PET/CT to Distinguish Between Radiation Injury and Tumor Progression

Memorial Sloan Kettering Cancer Center

Phase NA Completed
148 enrolled 9 charts
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡